Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology
GLIA Diagnostics Pty Ltd runs a Biotechnology operation from Sydney, New South Wales. Privately held, at gliadiagnostics.com. It holds one address on record, all in Australia. It employs 2 people, on the record. It lists diagnostics among its specialties. One Australian registration (ABN) is a confirmed match. The record links six similar brands, most of them in Biotechnology Research.
ABN34608130098
| GLIA DIAGNOSTICS PTY LTD | ABN 34608130098 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
GLIA Diagnostics (GLIA) is dedicated to transforming the diagnosis and prognosis of traumatic brain injury (TBI), with a particular emphasis on mild TBI (mTBI)/concussion, to deliver better outcomes for patients worldwide. Our mission is to advance the understanding of brain injury through rigorous research, education, and the clinical validation of a novel biomarker suite. When integrated into a purpose-built point-of-care (POC) device, this platform will provide an objective and reliable tool for both diagnosis and prognosis.
Our multidisciplinary team works closely with leading medical and scientific experts across the globe. By conducting robust clinical trials in diverse patient cohorts, we aim to validate our biomarker panel in parallel with complementary diagnostic modalities—establishing a comprehensive, evidence-based solution for concussion and broader TBI management.
With proven expertise in biomedical science, diagnostics, translational research, and device development, GLIA is uniquely positioned to lead innovation in this critical field. We are building GLIA as a collaborative hub, bringing together synergistic partners across Australasia and internationally. We believe the future of TBI diagnostics will be defined by integrated biomarker panels and multimodal approaches, enabling precise, real-time decision-making in both clinical practice and frontline environments.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
1 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
One New South Wales entity on the ABR: GLIA DIAGNOSTICS PTY LTD (ABN 34 608 130 098), high confidence.
2 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Australia only. Primary: Sydney, New South Wales 2000.
None linked to this brand.
Four tags on the brand's own list, among them diagnostics.
4 profiles list GLIA Diagnostics Pty Ltd as a peer — 56th percentile in Biotechnology. It lists ten peers of its own. NanoMed and INVICTA Prospects Group list it back.